
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.27 | 0.36 | 0.09 |
Shares | 99.73 | 99.73 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 29.70 | 29.60 |
Price to Book | 6.85 | 7.46 |
Price to Sales | 5.66 | 4.98 |
Price to Cash Flow | 20.86 | 19.07 |
Dividend Yield | 0.86 | 0.71 |
5 Years Earnings Growth | 9.98 | 13.22 |
Name | Net % | Category Average |
---|---|---|
Technology | 45.97 | 41.18 |
Consumer Cyclical | 18.71 | 13.97 |
Financial Services | 9.98 | 9.51 |
Communication Services | 9.08 | 12.88 |
Healthcare | 9.03 | 9.75 |
Industrials | 6.85 | 7.13 |
Basic Materials | 0.38 | 1.58 |
Number of long holdings: 38
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 7.52 | 514.05 | +0.60% | |
Amazon.com | US0231351067 | 7.39 | 220.07 | +1.71% | |
Apple | US0378331005 | 4.88 | 247.66 | +0.97% | |
Mastercard | US57636Q1040 | 4.50 | 559.24 | +0.32% | |
Oracle | US68389X1054 | 4.35 | 308.01 | +5.14% | |
Uber Tech | US90353T1007 | 4.22 | 94.08 | +0.73% | |
Amphenol | US0320951017 | 4.20 | 123.91 | +1.82% | |
US72352L1061 | 3.87 | 32.27 | +6.15% | ||
AMD | US0079031078 | 3.63 | 216.42 | +0.71% | |
Eli Lilly | US5324571083 | 3.25 | 819.40 | -1.69% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pioneer A | 7.97B | 17.90 | 26.37 | 15.82 | ||
Pioneer Fundamental Growth Y | 4.4B | 12.40 | 23.86 | 15.02 | ||
Pioneer Multi Asset Income Y | 4.45B | 19.11 | 15.43 | 8.74 | ||
Pioneer Disciplined Growth A | 2.16B | 19.21 | 25.59 | 15.79 | ||
Pioneer Core Equity A | 1.87B | 11.80 | 18.89 | 12.54 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review